1. Home
  2. ILMN vs STE Comparison

ILMN vs STE Comparison

Compare ILMN & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • STE
  • Stock Information
  • Founded
  • ILMN 1998
  • STE 1985
  • Country
  • ILMN United States
  • STE United States
  • Employees
  • ILMN N/A
  • STE N/A
  • Industry
  • ILMN Medical Specialities
  • STE Industrial Specialties
  • Sector
  • ILMN Health Care
  • STE Health Care
  • Exchange
  • ILMN Nasdaq
  • STE Nasdaq
  • Market Cap
  • ILMN 22.9B
  • STE 22.1B
  • IPO Year
  • ILMN 2000
  • STE 1992
  • Fundamental
  • Price
  • ILMN $141.09
  • STE $215.82
  • Analyst Decision
  • ILMN Buy
  • STE Buy
  • Analyst Count
  • ILMN 20
  • STE 6
  • Target Price
  • ILMN $160.68
  • STE $253.00
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • STE 613.9K
  • Earning Date
  • ILMN 11-04-2024
  • STE 02-05-2025
  • Dividend Yield
  • ILMN N/A
  • STE 1.05%
  • EPS Growth
  • ILMN N/A
  • STE N/A
  • EPS
  • ILMN N/A
  • STE 4.37
  • Revenue
  • ILMN $4,390,000,000.00
  • STE $5,325,525,000.00
  • Revenue This Year
  • ILMN N/A
  • STE $7.91
  • Revenue Next Year
  • ILMN $4.28
  • STE $6.37
  • P/E Ratio
  • ILMN N/A
  • STE $49.57
  • Revenue Growth
  • ILMN N/A
  • STE 15.75
  • 52 Week Low
  • ILMN $97.36
  • STE $197.82
  • 52 Week High
  • ILMN $156.66
  • STE $248.24
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 48.42
  • STE 41.81
  • Support Level
  • ILMN $138.88
  • STE $214.50
  • Resistance Level
  • ILMN $144.00
  • STE $219.65
  • Average True Range (ATR)
  • ILMN 4.58
  • STE 3.96
  • MACD
  • ILMN -0.05
  • STE 0.42
  • Stochastic Oscillator
  • ILMN 69.62
  • STE 53.84

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Share on Social Networks: